{"id":"https://openalex.org/W4401977207","doi":"https://doi.org/10.3389/flupu.2024.1465771","title":"Editorial: New insights into interferons and proinflammatory cytokines in lupus","display_name":"Editorial: New insights into interferons and proinflammatory cytokines in lupus","publication_year":2024,"publication_date":"2024-08-20","ids":{"openalex":"https://openalex.org/W4401977207","doi":"https://doi.org/10.3389/flupu.2024.1465771"},"language":"en","primary_location":{"id":"doi:10.3389/flupu.2024.1465771","doi":"https://doi.org/10.3389/flupu.2024.1465771","is_oa":true,"landing_page_url":"https://doi.org/10.3389/flupu.2024.1465771","pdf_url":"https://www.frontiersin.org/journals/lupus/articles/10.3389/flupu.2024.1465771/pdf","source":{"id":"https://openalex.org/S4387288846","display_name":"Frontiers in Lupus","issn_l":"2813-6934","issn":["2813-6934"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Lupus","raw_type":"journal-article"},"volume":null,"type":"editorial","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/lupus/articles/10.3389/flupu.2024.1465771/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5045509731","display_name":"Wendy I. White","orcid":"https://orcid.org/0000-0002-3286-0043","observed_orcids":["https://orcid.org/0000-0002-3286-0043"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Wendy I. White","raw_affiliation_strings":["AstraZeneca (United States), Gaithersburg, MD, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca (United States), Gaithersburg, MD, United States","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084517263","display_name":"Jillian M. Richmond","orcid":"https://orcid.org/0000-0003-1589-6770","observed_orcids":["https://orcid.org/0000-0003-1589-6770"]},"institutions":[{"id":"https://openalex.org/I166722992","display_name":"University of Massachusetts Chan Medical School","ror":"https://ror.org/0464eyp60","country_code":"US","type":"education","lineage":["https://openalex.org/I166722992"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jillian M. Richmond","raw_affiliation_strings":["Department of Dermatology, University of Massachusetts Medical School, Worcester, MA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, University of Massachusetts Medical School, Worcester, MA, United States","institution_ids":["https://openalex.org/I166722992"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5043900874","display_name":"Antonios Psarras","orcid":"https://orcid.org/0000-0002-6318-0171","observed_orcids":["https://orcid.org/0000-0002-6318-0171"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I4405264228","display_name":"Kennedy Institute of Rheumatology","ror":"https://ror.org/01ahsqc77","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149","https://openalex.org/I4405264228"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Antonios Psarras","raw_affiliation_strings":["Kennedy Institute of Rheumatology, NDORMS, University of Oxford, Oxford, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kennedy Institute of Rheumatology, NDORMS, University of Oxford, Oxford, United Kingdom","institution_ids":["https://openalex.org/I40120149","https://openalex.org/I4405264228"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5043900874","https://openalex.org/A5045509731","https://openalex.org/A5084517263"],"corresponding_institution_ids":["https://openalex.org/I166722992","https://openalex.org/I40120149","https://openalex.org/I4210150756","https://openalex.org/I4405264228"],"apc_list":{"value":2125,"currency":"USD","value_usd":2125},"apc_paid":{"value":2125,"currency":"USD","value_usd":2125},"fwci":null,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"2","issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11668","display_name":"interferon and immune responses","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11330","display_name":"Systemic Sclerosis and Related Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-i-interferon","display_name":"type I interferon","score":0.8140000104904175},{"id":"https://openalex.org/keywords/interferon-stimulated-genes","display_name":"interferon-stimulated genes","score":0.875},{"id":"https://openalex.org/keywords/antiphospholipid-antibodies","display_name":"antiphospholipid antibodies","score":0.8949999809265137},{"id":"https://openalex.org/keywords/antiphospholipid-syndrome","display_name":"antiphospholipid syndrome","score":0.9160000085830688},{"id":"https://openalex.org/keywords/thrombosis","display_name":"thrombosis","score":0.7239999771118164},{"id":"https://openalex.org/keywords/cutaneous-lupus-erythematosus","display_name":"cutaneous lupus erythematosus","score":0.8769999742507935},{"id":"https://openalex.org/keywords/interferon-beta","display_name":"interferon-beta","score":0.8420000076293945},{"id":"https://openalex.org/keywords/keratinocytes","display_name":"keratinocytes","score":0.9509999752044678},{"id":"https://openalex.org/keywords/lupus-nephritis","display_name":"lupus nephritis","score":0.746999979019165},{"id":"https://openalex.org/keywords/ackr2","display_name":"ACKR2","score":0.9829999804496765},{"id":"https://openalex.org/keywords/chemokine-degradation","display_name":"chemokine degradation","score":0.8970000147819519},{"id":"https://openalex.org/keywords/pro-inflammatory-cytokines","display_name":"inflammatory cytokines","score":0.828000009059906}],"concepts":[{"id":"https://openalex.org/C164027704","wikidata":"https://www.wikidata.org/wiki/Q3491837","display_name":"Proinflammatory cytokine","level":3,"score":0.9241431951522827},{"id":"https://openalex.org/C2776912625","wikidata":"https://www.wikidata.org/wiki/Q1485","display_name":"Systemic lupus erythematosus","level":3,"score":0.5213133692741394},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5153107643127441},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4865669310092926},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.23259785771369934},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1390189230442047},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.061173051595687866}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.3389/flupu.2024.1465771","doi":"https://doi.org/10.3389/flupu.2024.1465771","is_oa":true,"landing_page_url":"https://doi.org/10.3389/flupu.2024.1465771","pdf_url":"https://www.frontiersin.org/journals/lupus/articles/10.3389/flupu.2024.1465771/pdf","source":{"id":"https://openalex.org/S4387288846","display_name":"Frontiers in Lupus","issn_l":"2813-6934","issn":["2813-6934"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Lupus","raw_type":"journal-article"},{"id":"pmh:oai:ora.ox.ac.uk:uuid:76dab2ca-1854-4650-b8e3-3171c390f7ba","doi":null,"is_oa":true,"landing_page_url":"https://ora.ox.ac.uk/objects/uuid:76dab2ca-1854-4650-b8e3-3171c390f7ba/files/r00000108g","pdf_url":"https://ora.ox.ac.uk/objects/uuid:76dab2ca-1854-4650-b8e3-3171c390f7ba/files/r00000108g","source":{"id":"https://openalex.org/S4306402636","display_name":"Oxford University Research Archive (ORA) (University of Oxford)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I40120149","host_organization_name":"University of Oxford","host_organization_lineage":["https://openalex.org/I40120149"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Jisc Publications Router","raw_type":"Journal article"}],"best_oa_location":{"id":"doi:10.3389/flupu.2024.1465771","doi":"https://doi.org/10.3389/flupu.2024.1465771","is_oa":true,"landing_page_url":"https://doi.org/10.3389/flupu.2024.1465771","pdf_url":"https://www.frontiersin.org/journals/lupus/articles/10.3389/flupu.2024.1465771/pdf","source":{"id":"https://openalex.org/S4387288846","display_name":"Frontiers in Lupus","issn_l":"2813-6934","issn":["2813-6934"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Lupus","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4401977207.pdf","grobid_xml":"https://content.openalex.org/works/W4401977207.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2495905763","https://openalex.org/W3217299941","https://openalex.org/W1966609545","https://openalex.org/W3010213182","https://openalex.org/W2969898321","https://openalex.org/W2594800363","https://openalex.org/W4226464445","https://openalex.org/W2049115221","https://openalex.org/W2055711759","https://openalex.org/W6983892897"],"abstract_inverted_index":{"(https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1351446/full)":[0],"investigate":[1],"the":[2,11,58,62,66,71,85,98,182,186,262,287,299,303,372,380,401,415],"possible":[3],"association":[4],"between":[5],"type":[6,148],"I":[7,149],"IFN":[8,50,53,72,250],"dysfunction":[9],"and":[10,21,26,70,100,120,174,252,294,312,320,326,337,353],"disease":[12,367],"state":[13],"in":[14,43,79,112,127,151,172,215,271,286,350,389,408],"asymptomatic":[15],"individuals":[16],"with":[17,109,114,364],"antiphospholipid":[18],"antibodies":[19],"(aPL)":[20],"APS":[22,59,89,116,119],"patients.":[23],"SLE":[24,95],"patients":[25,80,96,113,128],"healthy":[27],"subjects":[28],"without":[29],"aPL":[30,131],"are":[31],"used":[32,318],"as":[33],"control":[34],"groups.":[35],"Seven":[36],"interferon":[37],"stimulated":[38],"genes":[39],"(ISGs)":[40],"were":[41,190,229,361],"evaluated":[42],"whole":[44],"blood":[45,319],"to":[46,137,179,329,332,407],"produce":[47],"a":[48,134,207,266,272],"composite":[49],"score.":[51],"Significant":[52],"activation":[54],"was":[55,76,106,156,170,203],"observed":[56],"across":[57],"spectrum,":[60],"although":[61],"exact":[63],"level":[64],"of":[65,88,125,146,220,231,257,264,268,274,290,298,305,335,371,382,396,403,417],"individual":[67],"gene":[68,251],"expression":[69,304],"score":[73],"varied.":[74],"This":[75],"found":[77,285],"even":[78],"who":[81],"did":[82],"not":[83,362],"meet":[84],"clinical":[86],"criteria":[87],"but":[90,181,200,358],"had":[91,165],"persistently":[92],"positive":[93],"aPL.":[94],"displayed":[97],"highest":[99],"most":[101,297],"consistent":[102],"activation.":[103],"Thrombosis":[104],"reoccurrence":[105],"positively":[107],"associated":[108,363],"certain":[110],"ISGs":[111,126],"secondary":[115],"(having":[117],"both":[118,248],"SLE).":[121],"The":[122,163,278,316],"elevated":[123],"presence":[124],"only":[129,204,213],"having":[130],"may":[132],"represent":[133],"potential":[135],"biomarker":[136],"stratify":[138],"high":[139],"risk":[140],"for":[141,185],"thrombosis":[142],"patients.An":[143],"intriguing":[144],"interplay":[145],"different":[147],"interferons":[150],"cutaneous":[152],"lupus":[153,275,345],"erythematosus":[154],"(CLE)":[155],"uncovered":[157],"by":[158,391],"Xu":[159],"et":[160,259],"al.(https://www.frontiersin.org/journals/lupus/articles/10.3389/flupu.2024.1359714/full":[161],").":[162],"researchers":[164,317],"previously":[166],"shown":[167],"that":[168,245,343,379],"IFN-\u03ba":[169,188,201,223,233,246],"overexpressed":[171],"lesional":[173],"non-lesional":[175],"CLE":[176],"keratinocytes":[177,196],"contributing":[178],"photosensitivity,":[180],"key":[183],"mechanisms":[184,410],"reported":[187],"production":[189],"unknown.":[191],"After":[192],"Poly":[193,236],"(I:C)":[194],"stimulation,":[195],"rapidly":[197],"produced":[198,205],"IFN-\u03b2,":[199],"instead":[202],"after":[206,234],"prolonged":[208],"time":[209],"delay.":[210],"Blocking":[211],"IFNAR":[212],"resulted":[214,349],"inhibiting":[216],"IFN-\u03ba.":[217],"Similarly,":[218],"inhibition":[219],"IFN-\u03b2":[221,225],"decreased":[222],"production.":[224],"knockout":[226],"cell":[227,314,355],"lines":[228],"incapable":[230],"producing":[232],"either":[235],"I:C":[237],"or":[238,368],"UVB":[239],"stimulation.":[240],"These":[241,376],"results":[242,377],"altogether":[243],"demonstrate":[244],"is":[247,284],"an":[249,253],"IFN-simulated":[254],"gene.The":[255],"work":[256,395],"Xia":[258],"al.":[260],"assesses":[261],"effect":[263],"losing":[265],"mechanism":[267],"chemokine":[269,280,310,384],"degradation":[270,385],"model":[273],"nephritis":[276],"(https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2016.00691/full#B23).":[277],"atypical":[279],"receptor":[281],"2":[282],"(ACKR2)":[283],"afferent":[288],"lymphatics":[289],"many":[291],"human":[292],"tissues":[293,321],"can":[295,386],"bind":[296],"CC":[300],"chemokines.":[301],"Through":[302],"ACKRs,":[306],"lymphatic":[307],"vessels":[308],"regulate":[309],"levels":[311,370],"immune":[313],"migration.":[315],"from":[322],"ACKR2deficient":[323],"lupus-prone":[324],"B6lpr":[325,341],"WTB6lpr":[327],"mice":[328,342],"determine":[330],"alterations":[331,360],"cellular":[333],"patterns":[334],"inflammation":[336],"organ":[338],"damage.":[339],"In":[340],"developed":[344],"nephritis,":[346],"ACKR2":[347],"deficiency":[348],"greater":[351,365],"T":[352],"B":[354],"tubulointerstitial":[356],"inflammation,":[357],"these":[359,398],"renal":[366],"higher":[369],"assessed":[373],"inflammatory":[374],"mediators.":[375],"show":[378],"loss":[381],"ACKR2-mediated":[383],"be":[387],"compensated":[388],"vivo":[390,409],"other":[392],"mechanisms.The":[393],"combined":[394],"all":[397],"papers":[399],"demonstrates":[400],"value":[402],"intracellular":[404],"signaling":[405],"events":[406],"further":[411],"shedding":[412],"light":[413],"on":[414],"complexity":[416],"SLE.Wendy":[418],"I.":[419],"White,":[420],"PhD":[421,425,429],"Jilian":[422],"M.":[423],"Richmond,":[424],"Antonios":[426],"Psarras,":[427],"MD,":[428]},"counts_by_year":[{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2024-08-29T00:00:00"}